Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · IEX Real-Time Price · USD
0.535
-0.027 (-4.74%)
Jun 20, 2024, 2:17 PM EDT - Market open

Ensysce Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018 - 2017
Cash & Equivalents
1.123.1512.260.190.34
Upgrade
Cash & Cash Equivalents
1.123.1512.260.190.34
Upgrade
Cash Growth
-64.30%-74.34%6215.06%-43.14%-79.41%
Upgrade
Receivables
0.10.280.4400.17
Upgrade
Other Current Assets
1.071.872.960.150.1
Upgrade
Total Current Assets
2.295.315.660.350.62
Upgrade
Property, Plant & Equipment
00.030.020.020
Upgrade
Other Long-Term Assets
0.420.560.73-0.020.01
Upgrade
Total Long-Term Assets
0.420.590.7500.01
Upgrade
Total Assets
2.715.8916.420.350.62
Upgrade
Accounts Payable
1.942.940.31.720.54
Upgrade
Current Debt
0.854.2912.774.272.62
Upgrade
Other Current Liabilities
0.542.233.411.024.14
Upgrade
Total Current Liabilities
3.339.4616.487.017.3
Upgrade
Long-Term Debt
00.144.4400
Upgrade
Other Long-Term Liabilities
0.030.313.6500
Upgrade
Total Long-Term Liabilities
0.030.458.0900
Upgrade
Total Liabilities
3.369.9124.587.017.3
Upgrade
Total Debt
0.854.4317.214.272.62
Upgrade
Debt Growth
-80.72%-74.24%303.08%62.91%-
Upgrade
Retained Earnings
-121.56-110.93-85.85-55.96-56.02
Upgrade
Shareholders' Equity
-0.32-3.71-7.88-6.44-6.68
Upgrade
Net Cash / Debt
0.27-1.29-4.95-4.08-2.28
Upgrade
Net Cash Per Share
0.12-7.15-58.91-59.27-21.98
Upgrade
Working Capital
-1.04-4.17-0.82-6.66-6.68
Upgrade
Book Value Per Share
-0.14-20.64-93.77-98.03-64.37
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).